Skip to content

Therapy Access

Access Built Over Years. Delivered Day One.

For more than a decade, we have built the expertise, relationships, and scale that help our health system partners achieve unmatched payer and drug access while preserving patient choice.

The Challenge

Evolving payer requirements, limited distribution networks, and administrative complexity can delay therapy, fragment care, and make it harder for patients to stay connected to their health system.

Partner Health Systems

Why Health Systems Partner With Us

Dedicated payer and drug access teams help health systems gain, maintain, and expand access while reducing operational burden through unmatched industry relationships.

Our Partners

Speed to Access

Accelerated access to payer networks and specialty medications from the start of the partnership, delivering on day one what can take years to build independently.

Dedicated Expertise

Specialized and highly experienced payer access and trade relations professionals focused exclusively on expanding and maintaining access.

Proven Relationships

Long-standing engagement with major PBMs, payers, and manufacturers across the specialty pharmacy ecosystem.

Network Scale

The collective strength of a nationwide network of leading health system specialty pharmacy programs.

Ongoing Support

Resources dedicated to accreditation, pipeline tracking, contracting, reporting, compliance, maintenance, optimization, and issue resolution.

Our Access Solutions

Every health system's path to access is different. That's why we offer a specialized and strategic approach that helps our partners navigate complexity, unlock new opportunities, and build a stronger foundation for long-term growth.

therapy workflow infographic

Payer Access & Contracting

Our team of highly specialized payer access experts with experience across every aspect of health system and pharmacy contracting, from PBM pathways and managed care to direct network agreements.

We support our partners through two distinct pathways:

Bespoke Payer Contracting: No two health systems face the same payer landscape. We take a bespoke approach, designing contracting strategies tailored to each organization's market dynamics, competitive position, and priorities. Our team works closely with each partner to identify the opportunities that will have the greatest impact on patient access, program growth, and long-term performance.

Network-level Contracting via the Shields Health Network. Built on the collective strength of the nation's leading health system specialty pharmacy programs, the Shields Health Network enables us to negotiate directly with payers, PBMs, and self-insured employers on behalf of our health system partners through a single participation agreement. The result is faster speed to access, unmatched scale, simplified contracting, and more opportunities to keep specialty care within the health system.

Payer Readiness & Performance Infrastructure

Both of our payer access pathways are backed by the same robust performance infrastructure. Our experts evaluate each specialty pharmacy program holistically, providing the clinical, operational, and reporting support needed to meet evolving payer requirements. From dual accreditation (URAC and ACHC) and disease-specific clinical programs to outcomes measurement, quality monitoring, and compliance reporting, we help our health system partners sustain access, maintain network participation, and reduce administrative burden.

$23B

of Payer Access Unlocked

90%+

Commercial Payer Access Acheived

1,000+

Contracts Secured

~500

Reports Produced Annually to Maintain Payer Access on Behalf of Our Partners

Drug Access & Trade Relations

As manufacturer requirements evolve, our drug access and trade relations teams help health systems navigate complexity and maintain access to specialty and limited distribution therapies.

We help our partners expand and maintain drug access through:

icon blue group

Manufacturer engagement and relationship management

icon blue medication

Strategic drug-specific program and design

icon blue protected file

Limited distribution drug access strategies

icon blue growth chart

Launch readiness planning

icon research blue

Drug pipeline monitoring

icon blue gear

Access expansion initiatives

icon blue pencil paper

Enhanced data reporting and ETASU REMS programs

blue icon costs duo

Ongoing trade relations support

The Results

90%+

Limited Distribution Drug Access

<2

Days Average Time to Therapy (PA TAT)

93%

Proportion of Days Covered (PDC)/Adherence rate

Get the Access That Powers Connected Performance

Expand access. Strengthen performance. Keep specialty care where it belongs.